Synthesis of N4- (2, 2-dimethyl-4- [ (dihydrogen phosphonoxy ] - 3-oxo-5-pyrido [1, 4] oxazin6-yl)-5-fluoro-N2- (3, 4, 5,-trimethoxyphenyl) -2, 4pyrimidinediamine disodium salt

Details for Australian Patent Application No. 2010266213 (hide)

Owner Rigel Pharmaceuticals, Inc.

Inventors Felfer, Ulfried; Giselbrecht, Karl-Heinz; Wolberg, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2010266213

PCT Pub. Number WO2011/002999

Priority 61/270,073 02.07.09 US

Filing date 1 July 2010

Wipo publication date 6 January 2011

International Classifications

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/002999 Priority application(s): WO2011/002999

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010266216-Systems and methods for zipknot ACL fixation

2010266210-Apparatus and method for replacing a diseased cardiac valve